| Literature DB >> 36246960 |
Yingyi Lu1, Fenglian Wang2, Haoxuan Ni1, Ying Sun3, Hailing Shi4.
Abstract
Diabetic retinopathy (DR) is the most common complication of diabetes and is often characterized by damage to retinal vascular microcirculation, resulting in retinal exudation, hemorrhage, fibrosis, and neovascularization. With the aging of my country's population, the incidence of DR is increasing year by year, and it has become one of the main blinding eye diseases in ophthalmic diseases also tends to be younger. So far, although the pathogenesis of DR is not completely clear, scholars generally believe that DR is based on the disorder of glucose metabolism, causing changes in the microcirculation of ocular tissues, nerves, and blood vessels, resulting in chronic damage to the nutrition and visual function of the eye disease. In order to explore the demand for cardiovascular disease treatment, make up for the lack of chronic diseases affecting people's physical harm, and improve the success rate of cardiovascular disease treatment, a method to observe the efficacy and myocardial remodeling of trimetazidine combined with metoprolol in elderly patients with coronary heart disease and heart failure based on integrated traditional Chinese and Western medicine was proposed. 54 elderly people over 60 years old are afraid of cardiovascular disease and take active protection. A method based on observation of integrated traditional Chinese and Western medicine was proposed, and at the same time, an intelligent medical monitoring system was constructed to better study, observe, and improve the efficacy of trimetazidine combined with metoprolol in elderly patients with coronary heart disease, heart failure, and myocardial impact of refactoring. The results of the study show that trimetazidine has a good clinical effect on ischemic cardiomyopathy heart failure based on the observation of integrated traditional Chinese and Western medicine.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36246960 PMCID: PMC9553493 DOI: 10.1155/2022/6098799
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.246
Figure 1Overall framework of intelligent monitoring system.
Figure 2PC data transmission sequence diagram.
Figure 3Data display flow chart.
Figure 4Original signal.
Figure 5Effect of hard threshold.
Figure 6Effect after applying soft threshold.
Figure 7Heart rate acquisition flow chart.
Blood oxygen calibration experimental data.
| Experiment number | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
|---|---|---|---|---|---|---|---|---|---|---|
| The system measures the | 0.6425 | 0.5818 | 0.5902 | 0.6284 | 0.7218 | 0.7024 | 0.6614 | 0.6841 | 0.5772 | 0.5546 |
| YX301 measured blood oxygen | 96% | 98% | 98% | 97% | 94% | 94% | 96% | 95% | 99% | 99% |
Figure 8Fitting diagram of blood oxygen calibration experiment.
Changes of various indexes of cardiac function in the two groups before and after treatment.
| Group | Number of cases | Left ventricular end diastolic diameter (mm) | Ejection fraction (%) | ||
|---|---|---|---|---|---|
| Before treatment | After treatment | Before treatment | After treatment | ||
| Treatment group | 30 | 56.97 ± 2.761 | 52.73 ± 3.618∗∗# | 35.26 ± 5.328 | 39.20 ± 6.346∗# |
| Control group | 30 | 55.91 ± 2.438 | 53.55 ± 2.315∗ | 36.42 ± 4.756 | 37.51 ± 6.374∗ |
Figure 9Comparison before and after treatment (P < 0.0001).
Figure 10Comparison before and after treatment (P < 0.001).
Comparison of the therapeutic effects of the two groups before and after heart failure treatment.
| Group | Efficacy of heart failure | |||
|---|---|---|---|---|
| Remarkable effect | Effective | Invalid | Total effective rate | |
| Treatment group | 16 (53) | 10(33) | 4 (14) | 26 (86) |
| Control group | 13 (43) | 9 (30) | 8 (27) | 22 (73) |
Comparison of ECG between the two groups before and after treatment.
| Group | ECG changes | |||
|---|---|---|---|---|
| Remarkable effect | Effective | Invalid | 25 (83) | |
| Treatment group | 15(50) | 10(33) | 5 (17) | 26 (86) |
| Control group | 12(40) | 12(40) | 6 (20) | 22 (80) |
Comparison of blood pressure and heart rate in the treatment group before and after treatment.
| Number of cases | Mean systolic blood pressure (mmHg) | Average heart rate (beats/min) | ||
|---|---|---|---|---|
| Before treatment | After treatment | Before treatment | After treatment | |
| 30 | 135 ± 15 | 128 ± 18 | 80 ± 6 | 81 ± 4 |